ARVO 2017 meeting

Reviewing anterior segment ARVO 2017 postersSo much basic science research is presented at this meeting, and most of it will be years before it makes its way to clinical trials. Let’s concentrate on research that might be of use to us in the exam room very soon.
ARVO 2017 showcases vision research advancesAdvances in presbyopia, dry eye and allergy, and age-related macular degeneration filled this year’s meeting of the Association for Research in Vision and Ophthalmology.
Posters presented at ARVO 2017 offer insight on cosmetic use and OSD, DemodexLeslie E. O’Dell, OD, FAAO, discusses posters she presented about cosmetics and the ocular surface and Demodex with Optometry Times Chief Optometric Editor Ernie Bowling, OD, MS, FAAO, at ARVO 2017 in Baltimore, MD.
Understanding corneal shape helps scleral lens fittingChristine W. Sindt, OD, FAAO, discusses her research in the shape of corneas and constructing the proper scleral lens for each patient with Optometry Times Chief Optometric Editor Ernie Bowling, OD, MS, FAAO, at ARVO 2017 in Baltimore, MD.
New research in how eye, brain health correlate presented at ARVO 2017John G. Flanagan, OD, PhD, FAAO, talks about his research and presentations regarding eye and brain health with Optometry Times Chief Optometric Editor Ernie Bowling, OD, MS, FAAO, at ARVO 2017 in Baltimore, MD.
New TFOS DEWS II report redefines dry eyeKelly K. Nichols, OD, MPH, PHD, FAAO, discusses the upcoming release of the TFOS DEWS II report and what ODs should expect with Optometry Times Chief Optometric Editor Ernie Bowling, OD, FAAO, at ARVO 2017 in Baltimore, MD.
Constructing the TFOS DEWS II report no easy taskAmy Gallant Sullivan, cofounder and executive director of TFOS, discusses what went into creating the DEWS II report with Optometry Times Chief Optometric Editor Ernie Bowling, OD, FAAO, at ARVO 2017 in Baltimore, MD.
Examining poster themes at ARVO 2017No one individual can digest the 5,647 posters and myriad oral presentations and panel discussions, but certain themes emerged, even to the casual observer. Poster numbers are included.
Aflibercept rivals laser for diabetic retinopathyIntravitreal aflibercept worked better than panretinal photocoagulation (PRP) for proliferative diabetic retinopathy (PDR) in a new head-to-head trial, according to researchers.
ARVO 2017 awards in spotlightAs eye and vision researchers gather this month for the 2017 meeting of the Association for Research in Vision and Ophthalmology (ARVO), four members will be recognized for their contributions to ophthalmology and vision research with a 2017 ARVO Achievement Award and lecture.